Xenon Pharmaceuticals Inc. Assets, Current
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-06
- 2026-06-30: Assets, Current $945.87M.
- 2026-03-31: Assets, Current $1.11B.
- 2025-12-31: Assets, Current $560.65M.
- 2025-09-30: Assets, Current $480.14M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $945.87M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $1.11B 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $560.65M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $480.14M 10-Q · filed 2025-11-03 | |
| 2025-06-30 | $500.25M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $565.54M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $635.26M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $659.64M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $728.09M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $707.20M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $644.96M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $531.01M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $544.62M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $533.35M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $600.30M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $649.18M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $794.80M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $545.62M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $559.02M 10-K · filed 2023-03-01 | |
| 2021-09-30 | $256.31M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $266.75M 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $283.26M 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $181.78M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $194.81M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $207.01M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $233.87M 10-Q/A · filed 2020-05-26 | |
| 2019-12-31 | $144.87M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $96.48M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $103.33M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $112.05M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $121.33M 10-K · filed 2020-03-09 | $121.44M 10-K · filed 2019-03-06 |
| 2018-09-30 | $129.49M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $64.35M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $36.66M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $44.82M 10-K · filed 2019-03-06 | |
| 2017-09-30 | $44.99M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $52.63M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $59.14M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $65.67M 10-K · filed 2018-03-07 | |
| 2016-09-30 | $71.35M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $53.39M 10-Q · filed 2016-08-03 | |
| 2016-03-31 | $58.27M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $60.87M 10-K · filed 2017-03-08 | |
| 2015-09-30 | $66.11M 10-Q · filed 2015-11-10 | |
| 2015-06-30 | $74.35M 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $77.05M 10-Q/A · filed 2015-08-13 | |
| 2014-12-31 | $84.94M 10-K · filed 2016-03-08 | |
| 2014-09-30 | $48.27M 10-Q · filed 2014-12-15 | |
| 2013-12-31 | $49.87M 10-K · filed 2015-03-12 |